A detailed history of Quent Capital, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 31 shares of CTLT stock, worth $1,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 31 -0.0%
Holding current value
$1,758
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jun 14, 2024

BUY
$32.18 - $46.57 $707 - $1,024
22 Added 244.44%
31 $1,000
Q4 2023

Jan 19, 2024

BUY
$32.18 - $46.57 $707 - $1,024
22 Added 244.44%
31 $1,000
Q3 2023

Jun 14, 2024

SELL
$44.2 - $50.2 $972 - $1,104
-22 Reduced 70.97%
9 $0
Q3 2023

Oct 10, 2023

SELL
$44.2 - $50.2 $972 - $1,104
-22 Reduced 70.97%
9 $0
Q4 2022

Jan 19, 2023

BUY
$41.39 - $81.0 $1,283 - $2,511
31 New
31 $0
Q2 2022

Aug 08, 2022

SELL
$87.2 - $114.05 $14,562 - $19,046
-167 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $15,729 - $20,789
167 New
167 $19,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.2B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.